IBDEI13I ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18292,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,18292,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,18293,0)
 ;;=L30.2^^94^905^132
 ;;^UTILITY(U,$J,358.3,18293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18293,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,18293,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,18293,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,18294,0)
 ;;=L30.4^^94^905^144
 ;;^UTILITY(U,$J,358.3,18294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18294,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,18294,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,18294,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,18295,0)
 ;;=L30.8^^94^905^135
 ;;^UTILITY(U,$J,358.3,18295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18295,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,18295,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,18295,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,18296,0)
 ;;=L30.9^^94^905^136
 ;;^UTILITY(U,$J,358.3,18296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18296,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,18296,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,18296,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,18297,0)
 ;;=L40.0^^94^905^253
 ;;^UTILITY(U,$J,358.3,18297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18297,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,18297,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,18297,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,18298,0)
 ;;=L40.1^^94^905^256
 ;;^UTILITY(U,$J,358.3,18298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18298,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,18298,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,18298,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,18299,0)
 ;;=L40.2^^94^905^11
 ;;^UTILITY(U,$J,358.3,18299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18299,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,18299,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,18299,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,18300,0)
 ;;=L40.3^^94^905^255
 ;;^UTILITY(U,$J,358.3,18300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18300,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,18300,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,18300,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,18301,0)
 ;;=L40.4^^94^905^157
 ;;^UTILITY(U,$J,358.3,18301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18301,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,18301,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,18301,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,18302,0)
 ;;=L40.8^^94^905^252
 ;;^UTILITY(U,$J,358.3,18302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18302,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,18302,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,18302,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,18303,0)
 ;;=L40.9^^94^905^254
 ;;^UTILITY(U,$J,358.3,18303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18303,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,18303,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,18303,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,18304,0)
 ;;=L50.9^^94^905^286
 ;;^UTILITY(U,$J,358.3,18304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18304,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,18304,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,18304,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,18305,0)
 ;;=L53.8^^94^905^147
 ;;^UTILITY(U,$J,358.3,18305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18305,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,18305,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,18305,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,18306,0)
 ;;=L53.9^^94^905^146
 ;;^UTILITY(U,$J,358.3,18306,1,0)
 ;;=^358.31IA^4^2
